British drugmaker GSK has settled lawsuits that accused Moderna’s COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, the companies said on Friday. Moderna said in a Friday press release that it settled GSK’s patent litigation …
Source: Claims Journal